AstraZeneca
AZN
$71.74
Share price
0.86%
Change (1 day)
-8.17%
Change (1 year)
Categories
AstraZeneca (AZN) - Net assets
Net assets on the balance sheet as of March 2025 : $41.13 Billion USD
According to AstraZeneca's latest financial reports the company has $41.13 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AstraZeneca - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$40.87 B | 4.35% |
| 2023-12-31 | $$39.16 B | 5.69% |
| 2022-12-31 | $$37.05 B | -5.67% |
| 2021-12-31 | $$39.28 B | 151.23% |
| 2020-12-31 | $$15.63 B | 7.14% |
| 2019-12-31 | $$14.59 B | 3.93% |
| 2018-12-31 | $$14.04 B | -15.61% |
| 2017-12-31 | $$16.64 B | -0.16% |
| 2016-12-31 | $$16.66 B | -9.94% |
| 2015-12-31 | $$18.50 B | -5.79% |
| 2014-12-31 | $$19.64 B | -15.51% |
| 2013-12-31 | $$23.25 B | -2.89% |
| 2012-12-31 | $$23.94 B | 2.05% |
| 2011-12-31 | $$23.46 B | 0.24% |
| 2010-12-31 | $$23.41 B | 12.43% |
| 2009-12-31 | $$20.82 B | 29.65% |
| 2008-12-31 | $$16.06 B | 7.68% |
| 2007-12-31 | $$14.91 B | -3.25% |
| 2006-12-31 | $$15.41 B | 12.6% |
| 2005-12-31 | $$13.69 B | -5.56% |
| 2004-12-31 | $$14.49 B | 9.35% |
| 2003-12-31 | $$13.25 B | 18.09% |
| 2002-12-31 | $$11.22 B | 16.59% |
| 2001-12-31 | $$9.62 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | $17.44 B | -57.58% | 🇺🇸 USA |
 Pfizer PFE | $90.63 B | 120.36% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 17.67% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $17.64 B | -57.11% | 🇬🇧 UK |
 Sanofi SNY | $80.51 B | 95.75% | 🇫🇷 France |
 Eli Lilly LLY | $15.84 B | -61.47% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $78.10 B | 89.90% | 🇺🇸 USA |
 Abbott Laboratories ABT | $49.06 B | 19.29% | 🇺🇸 USA |
 Biogen BIIB | $16.97 B | -58.72% | 🇺🇸 USA |
 Novartis NVS | $38.45 B | -6.51% | 🇨🇭 Switzerland |